“Early Imaging Marker of Progressive Glioblastoma: a window of opportunity”
Na Tosha N. Gatson
doi: https://doi.org/10.1101/2020.04.25.20079665
Na Tosha N. Gatson
1Neuroscience Institute, Geisinger Health, Danville, PA, 17822
2Cancer Institute, Geisinger Health, Danville, PA, 17822
3Geisinger Commonwealth School of Medicine, Geisinger Commonwealth School of Medicine, Scranton, PA, 18509
MD, PhD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted April 30, 2020.
“Early Imaging Marker of Progressive Glioblastoma: a window of opportunity”
Na Tosha N. Gatson
medRxiv 2020.04.25.20079665; doi: https://doi.org/10.1101/2020.04.25.20079665
Subject Area
Subject Areas
- Addiction Medicine (344)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2635)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12205)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4079)
- Geriatric Medicine (387)
- Health Economics (679)
- Health Informatics (2636)
- Health Policy (1000)
- Hematology (362)
- HIV/AIDS (849)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3855)
- Nursing (209)
- Nutrition (572)
- Oncology (2015)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (449)
- Public and Global Health (6509)
- Radiology and Imaging (1395)
- Respiratory Medicine (870)
- Rheumatology (402)
- Sports Medicine (342)
- Surgery (442)
- Toxicology (52)
- Transplantation (185)
- Urology (165)